linsidomine has been researched along with Myasthenia Gravis in 1 studies
linsidomine: RN given refers to parent cpd; structure
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, J | 1 |
| Wang, HB | 1 |
| Wang, WZ | 1 |
1 other study available for linsidomine and Myasthenia Gravis
| Article | Year |
|---|---|
[Effects of nitric oxide donor on autoimmune myasthenia gravis in rats].
Topics: Animals; Female; Molsidomine; Myasthenia Gravis; Nitric Oxide Donors; Rats; Rats, Inbred Lew; Recept | 2004 |